APSR2026-1013

 
Late-Breaking
Submitted
Poster Presentation
 
AP12-020
P97
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1205582-46904-APSR2026-1013_439996.pdf
Format: PDF Only
16. Interstitial Lung Disease
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hongyan Wang * The Third Affiliated Hospital of Inner Mongolia Medical University Respiratory and Critical Care Medicine Department baotou China
Hongjun Tian - The Third Affiliated Hospital of Inner Mongolia Medical University Respiratory and Critical Care Medicine Department baotou China
Mingyu Yan - The Third Affiliated Hospital of Inner Mongolia Medical University Respiratory and Critical Care Medicine Department baotou China
Xiyuan Xu - The Third Affiliated Hospital of Inner Mongolia Medical University Respiratory and Critical Care Medicine Department baotou China
Pengfei Xuan - The Third Affiliated Hospital of Inner Mongolia Medical University Respiratory and Critical Care Medicine Department baotou China
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Hongyan
Wang
3250522954@qq.com
+8615164950006
31-40
China
Original Research
Single-Cell and Multi-Omics Analysis Identifies Common Pathogenic Networks Linking COPD and IPF
Maximum 25 words
Abstract Content
Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are debilitating, progressive respiratory disorders that share overlapping pathogenic pathways. However, the precise shared molecular signatures driving both conditions remain poorly characterized. This study aimed to elucidate these common molecular mechanisms and identify shared biomarkers linking COPD and IPF.
Public transcriptomic datasets for COPD and IPF were analyzed to identify common differentially expressed genes (DEGs). Machine learning algorithms were leveraged to construct a diagnostic model for COPD, while Cox regression analysis was applied to establish a prognostic signature for IPF. To comprehensively characterize these shared features, we performed miRNA-target regulatory network modeling, immune infiltration profiling, single-cell RNA sequencing (scRNA-seq) dissection, and clinical validation via serum proteomics in patients with combined pulmonary fibrosis and emphysema (CPFE).
We identified 114 shared DEGs between COPD and IPF, which were primarily enriched in immune immunoregulation, extracellular matrix (ECM) remodeling, and integrin signaling pathways. The COPD diagnostic model demonstrated robust predictive performance, and the IPF prognostic signature effectively stratified patient survival risk. Concurrently, five core feature genes (AEBP1, SLC1A3, HSD11B1, SH3PXD2B, and C2orf88) were prioritized. Regulatory network analysis highlighted 200 potential miRNAs, among which hsa-let-7b-5p, hsa-let-7c-5p, hsa-miR-17-5p, hsa-miR-27a-3p, and hsa-miR-34a-5p emerged as key multi-target regulators. Immune profiling and scRNA-seq mapping demonstrated that these feature genes are intricately linked to macrophage activation, fibroblast dysfunction, and ECM remodeling. Finally, proteomic analysis confirmed the significant differential expression of AEBP1 in the serum of CPFE patients.
This study deciphers the shared molecular architecture and regulatory networks bridging COPD and IPF. Immune-mediated inflammation, aberrant macrophage activation, and pathological ECM remodeling represent crucial mechanistic links between these disorders. The identified multi-omic signature, particularly AEBP1, holds strong promise as a biomarker and therapeutic target for complex chronic lung diseases like CPFE.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
COPD; IPF; CPFE; AEBP1; Biomarker; Single-cell RNA sequencing
maximum 3 keywords and no abbreviations, separated by commas
The authors acknowledge the investigators who generated and made publicly available the datasets used in this study. This work was supported by the Inner Mongolia Science and Technology Innovation Guidance Project (CXYD2022BT07). The authors declare no conflicts of interest.
289